journal article·2020-02

3D-microenvironments initiate TCF4 expression rescuing nuclear β-catenin activity in MCF-7 breast cancer cells

Sara Sergio, Addolorata Maria Luce Coluccia, Enrico Domenico Lemma, Barbara Spagnolo, Daniele Vergara, Michele Maffia, Massimo De Vittorio, Ferruccio Pisanello

Acta Biomaterialia· Volume 103
Publisher page

Abstract

Mechanical cues sensed by tumor cells in their microenvironment can influence important mechanisms including adhesion, invasion and proliferation. However, a common mechanosensitive protein and/or pathway can be regulated in different ways among diverse types of tumors. Of particular interest are human breast epithelial cancers, which markedly exhibit a heterogeneous pattern of nuclear β-catenin localization, a protein known to be involved in both mechanotransduction and tumorigenesis. β-catenin can be aberrantly accumulated in the nucleus wherein it binds to and activates lymphoid enhancer factor/T cell factor (LEF/TCF) transcription factors. At present, little is known about how mechanical cues are integrated into breast cancer cells harboring impaired mechanisms of β-catenin's nuclear uptake and/or retention. This prompted us to investigate the influence of mechanical cues on MCF-7 human breast cancer cells which are known to fail in relocating β-catenin into the nucleus due to very low baseline levels of LEF/TCFs. Exploiting three-dimensional (3D) microscaffolds realized by two-photon lithography, we show that surrounding MCF-7 cells have not only a nuclear pool of β-catenin, but also rescue from their defective expression of TCF4 and boost invasiveness. Together with heightened amounts of vimentin, a β-catenin/TCF-target gene regulator of proliferation and invasiveness, such 3D-elicited changes indicate an epithelial-to-mesenchymal phenotypic switch of MCF-7 cells. This is also consistent with an increased in situ MCF-7 cell proliferation that can be abrogated by blocking β-catenin/TCF-transcription activity. Collectively, these data suggest that 3D microenvironments are per se sufficient to prime a TCF4-dependent rescuing of β-catenin nuclear activity in MCF-7 cells. The employed methodology could, therefore, provide a mechanism-based rationale to dissect further aspects of mechanotranscription in breast cancerogenesis, somewhat independent of β-catenin's nuclear accumulation. More importantly, by considering the heterogeneity of β-catenin signaling pathway in breast cancer patients, these data may open alternative avenues for personalized disease management and prevention. STATEMENT OF SIGNIFICANCE: Mechanical cues play a critical role in cancer pathogenesis. Little is known about their influence in breast cancer cells harboring impaired mechanisms of β-catenin's nuclear uptake and/or retention, involved in both mechanotransduction and tumorigenesis. We engineered 3D scaffold, by two-photon lithography, to study the influence of mechanical cues on MCF-7 cells which are known to fail in relocating β-catenin into the nucleus. We found that 3D microenvironments are per se sufficient to prime a TCF4-dependent rescuing of β-catenin nuclear activity that boost cell proliferation and invasiveness. Thus, let us suggest that our system could provide a mechanism-based rationale to further dissect key aspects of mechanotranscription in breast cancerogenesis and progression, somewhat independent of β-catenin's nuclear accumulation.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cellular Mechanics and Interactions · Wnt/β-catenin signaling in development and cancer · Cell Adhesion Molecules Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (72)

Show source-provided references
1. A tense situation: forcing tumour progression10.1038/nrc2544 ↗
2. The mechanical microenvironment in cancer: how physics affects tumours10.1016/j.semcancer.2015.09.001 ↗
3. Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors10.1016/j.semcancer.2010.04.004 ↗
4. Tumor mechanosensing and its therapeutic potential10.1002/jcb.26786 ↗
5. Gene expression perturbation in vitro—A growing case for three-dimensional (3D) culture systems10.1016/j.semcancer.2005.06.009 ↗
6. Taking cell-matrix adhesions to the third dimension10.1126/science.1064829 ↗
7. Capturing complex 3D tissue physiology in vitro10.1038/nrm1858 ↗
8. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer10.1146/annurev.cellbio.22.010305.104315 ↗
9. Breakdown of cell-collagen networks through collagen remodeling
10. The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures10.1186/1471-2407-10-263 ↗
11. Tumor cell migration in complex microenvironments10.1007/s00018-012-1115-1 ↗
12. Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis10.1038/s41413-018-0008-9 ↗
13. Application of synthetic polymeric scaffolds in breast cancer 3D tissue cultures and animal tumor models10.1155/2017/8074890 ↗
14. Physical limits of cell migration: control by ecm space and nuclear deformation and tuning by proteolysis and traction force10.1083/jcb.201210152 ↗
15. Plasticity of cell migration: a multiscale tuning model10.1083/jcb.200909003 ↗
16. Collagen fiber array of peritumoral stroma influences epithelial-to-mesenchymal transition and invasive potential of mammary cancer cells10.3390/jcm8020213 ↗
17. Tunable mechanical properties of stent-like microscaffolds for studying cancer cell recognition of stiffness gradients10.1016/j.mee.2018.01.007 ↗
18. Studying cell mechanobiology in 3D: the two-photon lithography approach
19. Microenvironmental stiffness of 3D polymeric structures to study invasive rates of cancer cells10.1002/adhm.201700888 ↗
20. Three-dimensional cage-like microscaffolds for cell invasion studies10.1038/srep10531 ↗
21. The many faces and functions of β‐catenin10.1038/emboj.2012.150 ↗
22. Decisions, decisions: β-catenin chooses between adhesion and transcription10.1016/j.tcb.2005.03.002 ↗
23. Convergence of wnt, ß-Catenin, and cadherin pathways10.1126/science.1094291 ↗
24. The β-Catenin axis integrates multiple signals downstream from RET/Papillary thyroid carcinoma leading to cell proliferation10.1158/0008-5472.CAN-08-1982 ↗
25. Phosphorylation and free pool of β-Catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration10.1074/jbc.274.15.10173 ↗
26. Regulation of β-Catenin structure and activity by tyrosine phosphorylation10.1074/jbc.M100194200 ↗
27. BCR‐ABL stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylation10.1038/sj.emboj.7601485 ↗
28. β-catenin and its regulatory network10.1016/j.humpath.2005.02.002 ↗
29. Nucleo-cytoplasmic distribution of β-catenin is regulated by retention10.1242/jcs.02864 ↗
30. Regulation of β-Catenin nuclear dynamics by GSK-3β involves a LEF-1 positive feedback loop10.1111/j.1600-0854.2011.01207.x ↗
31. Wnt signaling through inhibition of β-Catenin degradation in an intact axin1 complex10.1016/j.cell.2012.05.002 ↗
32. Factors affecting the nuclear localization of β-Catenin in normal and malignant tissue10.1002/jcb.24803 ↗
33. Characterization of a beta-catenin nuclear localization defect in MCF-7 breast cancer cells10.1016/j.yexcr.2016.01.020 ↗
34. Expression patterns of β-catenin in in situ and invasive breast cancer10.1053/ejso.1999.1017 ↗
35. Targeting WNT signaling in colorectal cancer. a review in the theme: cell signaling: proteins, pathways and mechanisms10.1152/ajpcell.00117.2015 ↗
36. Role of WNT/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance10.2147/JHC.S156701 ↗
37. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation10.1038/modpathol.2010.205 ↗
38. Cytoplasmic localization of β-Catenin is a marker of poor outcome in breast cancer patients10.1158/1055-9965.EPI-09-0741 ↗
39. Evolutionary conservation of early mesoderm specification by mechanotransduction in Bilateria10.1038/ncomms3821 ↗
40. A tense situation: forcing Tumour progression10.1038/nrc2544 ↗
41. Actomyosin-Mediated cellular tension drives increased tissue stiffness and β-Catenin activation to induce epidermal hyperplasia and tumor growth10.1016/j.ccr.2011.05.008 ↗
42. Nanopatterned polymer substrates promote endothelial proliferation by initiation of β-catenin transcriptional signaling10.1016/j.actbio.2012.04.018 ↗
43. Mechanical properties of β-Catenin revealed by single-molecule experiments10.1016/j.bpj.2012.07.051 ↗
44. Mechanical factors activate ß‐catenin‐dependent oncogene expression in APC1638N/+ mouse colon10.2976/1.2955566 ↗
45. Mechanical properties tunability of three-dimensional polymeric structures in two-photon lithography
46. Wnt–β-catenin–Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer10.1038/bjc.2011.269 ↗
47. Restricted high level expression of tcf-4 protein in intestinal and mammary gland epithelium10.1016/S0002-9440(10)65247-9 ↗
48. Mechanisms of tumor cell extravasation in an in vitro microvascular network platform10.1039/c3ib40149a ↗
49. Cadherin-11 is expressed in invasive breast cancer cell lines
50. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression10.1073/pnas.060025397 ↗
51. FH535 inhibits proliferation and migration of colorectal cancer cells by regulating Cyclina2 and claudin1 gene expression
52. FH535 inhibited migration and growth of breast cancer cells10.1371/journal.pone.0044418 ↗
53. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling10.1083/jcb.200102028 ↗
54. Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma10.1073/pnas.0610299104 ↗
55. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic WNT signaling10.1126/scitranslmed.3003808 ↗
56. The regulation of β-catenin activity and function in cancer: therapeutic opportunities10.18632/oncotarget.15687 ↗
57. A small-molecule inhibitor of TCF/β-catenin signaling down-regulates PPARγ and PPARδ activities10.1158/1535-7163.MCT-07-2063 ↗
58. Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains10.1002/j.1460-2075.1996.tb00719.x ↗
59. Adhesion signaling: how β-catenin interacts with its partners10.1016/S0960-9822(01)00473-0 ↗
60. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis10.1093/carcin/bgq269 ↗
61. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells
62. Tumor-induced solid stress activates β-catenin signaling to drive malignant behavior in normal, tumor-adjacent cells, Bioessays: news and reviews in molecular
63. WNT signalling and haematopoiesis: a WNT–WNT situation10.1038/nri1529 ↗
64. Wnt/β-Catenin signaling and disease10.1016/j.cell.2012.05.012 ↗
65. Regulation of transcription factors by protein degradation10.1007/PL00000760 ↗
66. Tissue mechanics modulate microRNA-dependent pten expression to regulate malignant progression10.1038/nm.3497 ↗
67. Molecular and cellular biology of intermediate filaments10.1146/annurev.bi.57.070188.003113 ↗
68. Transactivation of vimentin by β-Catenin in human breast cancer cells
69. VImentin expression in cervical carcinomas: association with invasive and migratory potential10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G ↗
70. Vimentin contributes to human mammary epithelial cell migration10.1242/jcs.112.24.4615 ↗
71. The epithelial-to-mesenchymal transition in cancer10.3390/cancers10020052 ↗
72. Translating epithelial mesenchymal transition markers into the clinic: novel insights from proteomics10.1016/j.euprot.2016.01.003 ↗